A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis - 06/11/18
Doi : 10.1016/j.jaci.2018.06.045
Davide Martorana, PhD a, ∗, Ana Márquez, PhD b, ∗, F. David Carmona, PhD c, Francesco Bonatti, PhD a, Alessia Adorni, PhD a, Maria L. Urban, MD d, Federica Maritati, MD d, Eugenia Accorsi Buttini, MD d, Chiara Marvisi, MD d, Alessandra Palmisano, MD d, Giovanni M. Rossi, MD d, Giorgio Trivioli, MD d, Paride Fenaroli, MD d, Lucio Manenti, MD d, Maria Nicastro, BSS d, Monia Incerti, BSS d, Davide Gianfreda, MD d, Stefano Bani, MD d, Stefania Ferretti, MD e, Domenico Corradi, MD f, Federico Alberici, MD, PhD g, Giacomo Emmi, MD, PhD h, Gerardo Di Scala, MD h, Gabriella Moroni, MD i, Antonio Percesepe, MD a, Paul J. Scheel, MD j, Eric Vermeer, MD, PhD k, Eric F. van Bommel, MD k, Javier Martín, MD, PhD b, ‡, Augusto Vaglio, MD, PhD d, ‡ 
a Medical Genetics Unit, Parma University Hospital, Parma, Italy
d Nephrology Unit, Parma University Hospital, Parma, Italy
e Urology Unit, Parma University Hospital, Parma, Italy
f Pathology Unit, Parma University Hospital, Parma, Italy
b Instituto de Parasitología y Biomedicina Lopez-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain
c Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain
g Nephrology Unit, San Carlo Borromeo Hospital, Milan, Italy
h Internal Medicine, University of Firenze, Firenze, Italy
i Nephrology Unit, Fondazione Ca' Granda IRCCS Ospedale Maggiore, Milan, Italy
j Department of Medicine, Washington University, St Louis, Mo
k Department of Internal Medicine, Albert Schweitzer Hospital, Dutch National Center of Expertise for Retroperitoneal Fibrosis, Dordrecht, The Netherlands
| Supported in part by “A tailored approach to the immune-monitoring and clinical management of viral and autoimmune diseases,” which was funded by the Regione Emilia-Romagna within the Programma di Ricerca Regione-Università 2010–2012, and “Tailoring Rituximab treatment in ANCA-associated vasculitis; a genetic and an immunological approach,” which was funded by the Regione Emilia-Romagna within the Programma di ricerca Regione-Università Giovani Ricercatori “Alessandro Liberati” 2013, Fondazione Emma ed Ernesto Rulfo per la Genetica Medica. A.M. is recipient of a “Juán de la Cierva” fellowship (IJCI-2014-20322) from the Spanish Ministry of Economy and Competitiveness. F.D.C. is recipient of a grant from the “Ramon y Cajal” programme (RYC-2014-16458) from the Spanish Ministry of Economy, Industry and Competitiveness. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 5
P. 1662-1665 - novembre 2018 Retour au numéro
Article précédent
- In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients
- Neda Farahi, Chrystalla Loutsios, Nicola Tregay, Adam K.A. Wright, Rachid Berair, Laurence S.C. Lok, Daniel Gillett, Ian Cullum, Rosalind P. Simmonds, Charlotte Summers, Anna Wong, Chandra K. Solanki, John Buscombe, Pee Hwee Pang, Arthikkaa Thavakumar, A. Michael Peters, Christopher E. Brightling, Alison M. Condliffe, Edwin R. Chilvers
- Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
- Lisa R. Forbes, Tiphanie P. Vogel, Megan A. Cooper, Johana Castro-Wagner, Edith Schussler, Katja G. Weinacht, Ashley S. Plant, Helen C. Su, Eric J. Allenspach, Mary Slatter, Mario Abinun, Desa Lilic, Charlotte Cunningham-Rundles, Olive Eckstein, Peter Olbrich, R. Paul Guillerman, Niraj C. Patel, Yesim Y. Demirdag, Christa Zerbe, Alexandra F. Freeman, Steven M. Holland, Paul Szabolcs, Andrew Gennery, Troy R. Torgerson, Joshua D. Milner, Jennifer W. Leiding
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?